Accendra Health, Inc. filed a current report on November 2, 2026, disclosing that two of its wholly-owned subsidiaries entered into a third amendment to their receivables purchase agreement, extending the scheduled termination date of the company's receivables securitization program to October 2029.

Key Highlights

  • Amendment date: The Third Amendment to the Amended and Restated Receivables Purchase Agreement was executed on October 29, 2026.
  • Parties involved: Accendra Funding LLC, as Seller, and Byram Healthcare Centers, Inc., as Servicer, both wholly-owned subsidiaries of Accendra Health, Inc., are parties to the amended agreement.
  • Extended termination date: The RPA Amendment extends the Scheduled Termination Date until October 2029, with standard contingencies, according to the filing.
  • Administrative Agent: PNC Bank, National Association serves as Administrative Agent, and PNC Capital Markets LLC serves as Structuring Agent under the agreement.
  • Revised provisions: The amendment also revises account control provisions and reporting obligations, the filing disclosed.
  • Existing relationship: The filing noted that PNC Bank, National Association and PNC Capital Markets LLC "have various relationships with the Company and its subsidiaries involving the provision of financial services, including investment banking, commercial banking, advisory, cash management, custody and trust services."

Accendra Health and Byram Healthcare Amend Receivables Purchase Agreement

According to the filing, Accendra Health, Inc. (NYSE:ACH), a Virginia-incorporated company headquartered at 4435 Waterfront Drive, Suite 300, Glen Allen, Virginia, operates through subsidiaries that include Accendra Funding LLC and Byram Healthcare Centers, Inc. The receivables securitization program, in which Byram acts as Servicer and Accendra Funding acts as Seller, is a financing structure that involves the purchase and sale of receivables under the Amended and Restated Receivables Purchase Agreement originally dated December 31, 2025.

The filing disclosed that the Third Amendment, referred to as the "RPA Amendment," extends the Scheduled Termination Date of the program until October 2029, subject to standard contingencies. In addition to the extension, the amendment revises account control provisions and reporting obligations. The filing noted that a complete copy of the RPA Amendment will be filed as an exhibit to the company's Annual Report for the fiscal year ending December 31, 2026, and that the description provided in this current report is a summary "qualified in its entirety by reference to the complete terms of the RPA Amendment."

The filing also reported that on November 2, 2026, the company issued a press release related to the amendment, furnished as Exhibit 99.1. The current report was signed by Jonathan A. Leon, Executive Vice President and Chief Financial Officer of Accendra Health, Inc., on November 2, 2026.

What Was Disclosed

Accendra Health, Inc. disclosed the execution of a third amendment to its receivables securitization program, extending its scheduled termination to October 2029, along with revised account control and reporting provisions, through a current report filed November 2, 2026.